Search. Read. Cite.

Easy to search. Easy to read. Easy to cite with credible sources.

Articles by W Koenig (7)

Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium

N. L Smith, M. H Chen, A Dehghan, D. P Strachan, S Basu, N Soranzo, C Hayward, I Rudan, M Sabater Lleal, J. C Bis, M. P. M de Maat, A Rumley, X Kong, Q Yang, F. M. K Williams, V Vitart, H Campbell, A Malarstig, K. L Wiggins, C. M Van Duijn, W. L McArdle, J. S Pankow, A. D Johnson, A Silveira, B McKnight, A. G Uitterlinden, Aleksic Wellcome Trust Case Control Consortium;, J. B Meigs, A Peters, W Koenig, M Cushman, S Kathiresan, J. I Rotter, E. G Bovill, A Hofman, E Boerwinkle, G. H Tofler, J. F Peden, B. M Psaty, F Leebeek, A. R Folsom, M. G Larson, T. D Spector, A. F Wright, J. F Wilson, A Hamsten, T Lumley, J. C. M Witteman, W Tang and C. J. O'Donnell

Circulation 121 ( 12 ): 1382 - 1392 , 2010

Association of Novel Genetic Loci With Circulating Fibrinogen Levels: A Genome-Wide Association Study in 6 Population-Based Cohorts

A Dehghan, Q Yang, A Peters, S Basu, J. C Bis, A. R Rudnicka, M Kavousi, M. H Chen, J Baumert, G. D.O Lowe, B McKnight, W Tang, M de Maat, M. G Larson, S Eyhermendy, W. L McArdle, T Lumley, J. S Pankow, A Hofman, J. M Massaro, F Rivadeneira, M Kolz, K. D Taylor, C. M van Duijn, S Kathiresan, T Illig, Y. S Aulchenko, K. A Volcik, A. D Johnson, A. G Uitterlinden, G. H Tofler, C Gieger, Psaty Wellcome Trust Case Control Consortium, D. J Couper, E Boerwinkle, W Koenig, C. J O`Donnell, J. C Witteman, D. P Strachan, N. L Smith and A. R. Folsom

Circulation: Cardiovascular Genetics 2 ( 2 ): 125 - 133 , 2009

Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein: Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)

P. M Ridker, F. A.H Fonseca, J Genest, A. M Gotto, J. J.P Kastelein, W Koenig, P Libby, A. J Lorenzatti, B. G Nordestgaard, J Shepherd, J. T Willerson, R. J Glynn and for the JUPITER Study Group

Circulation: Cardiovascular Quality and Outcomes 2 ( 6 ): 616 - 623 , 2009

Rosuvastatin for Primary Prevention Among Individuals With Elevated High-Sensitivity C-Reactive Protein and 5% to 10% and 10% to 20% 10-Year Risk: Implications of the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial for "Intermediate Risk"

P. M Ridker, J. G MacFadyen, B. G Nordestgaard, W Koenig, J. J. P Kastelein, J Genest and R. J. Glynn

Circulation: Cardiovascular Quality and Outcomes 3 ( 5 ): 447 - 452 , 2010

Cystatin C and Cardiovascular Risk

N Taglieri, W Koenig and J. C. Kaski

Clinical Chemistry 55 ( 11 ): 1932 - 1943 , 2009

Non-conventional markers of atherosclerosis before and after gastric banding surgery

U Hanusch Enserer, G Zorn, J Wojta, C. W Kopp, R Prager, W Koenig, M Schillinger, M Roden and K. Huber

European Heart Journal 30 ( 12 ): 1516 - 1524 , 2009

Mediterranean diet and inflammatory response in myocardial infarction survivors

D. B Panagiotakos, K Katsouyanni, T Bellander, M Grau, W Koenig, T Lanki, R Pistelli, A Schneider, A Peters and on behalf of the AIRGENE Study Group

International Journal of Epidemiology 38 ( 3 ): 856 - 866 , 2009